CLINICAL_TRIALS
trial_result
· 2020-08-20
Clinical Trial Update: LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris [Phase 3]
Summary
Phase 3 trial update for LEO 90100 with a twice-weekly maintenance regimen in psoriasis vulgaris completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2020-08-20